What is Gujarat Kidney And Super Speciality Net Margin %?
Gujarat Kidney And Super SpecialityNSE:GKSL +0.83%18 Net Margin % is 16.49% as of Mar. 2026, which is 17% above its 10-year median of 14.13. GuruFocus rates NSE:GKSL with a GF Score™ of 18/100. The stock has 3 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Gujarat Kidney And Super Speciality ranks better than 92.96% on this metric.
NSE:GKSL'
s Net Margin % Range Over the Past 10 Years
Min: 7.73 Med: 14.13 Max: 23.39
Current: 18.58
NSE:GKSL's Net Margin % is ranked better than 92.96% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 2.885
vs NSE:GKSL: 18.58
Gujarat Kidney And Super Speciality (NSE:GKSL) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Gujarat Kidney And Super Speciality Net Margin % Related Terms
Gujarat Kidney And Super Speciality Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gujarat Kidney And Super Speciality Net Margin % Chart
Gujarat Kidney And Super Speciality Annual Data
Trend
Mar23
Mar24
Mar25
Mar26
Net Margin %
7.73
9.36
23.39
18.90
Gujarat Kidney And Super Speciality Quarterly Data
NSE:GKSL vs HCA, THC, DVA: Net Margin % Comparison
For the Medical Care Facilities subindustry, Gujarat Kidney And Super Speciality's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gujarat Kidney And Super Speciality Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Gujarat Kidney And Super Speciality's Net Margin % distribution charts can be found below:
* The bar in red indicates where Gujarat Kidney And Super Speciality's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gujarat Kidney And Super Speciality (NSE:GKSL) has a Net Margin % of 16.49% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Gujarat Kidney And Super Speciality and its competitors. This is 17% above median its historical median of 14.13. Over the past decade, Gujarat Kidney And Super Speciality's Net Margin % has ranged from 7.73 to 23.39. According to the industry distribution chart, Gujarat Kidney And Super Speciality ranks #47 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 7%.
Is Gujarat Kidney And Super Speciality's Net Margin % too high?
Gujarat Kidney And Super Speciality's current Net Margin % of 16.49% is 17% above median its 10-year median of 14.13. Over the past 10 years, this metric has ranged from a low of 7.73 to a high of 23.39. The Healthcare Providers & Services industry median Net Margin % is 2.89. Gujarat Kidney And Super Speciality's value of 16.49% is 471.6% above this industry median. Based on the distribution chart, Gujarat Kidney And Super Speciality ranks #47 out of 668 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Gujarat Kidney And Super Speciality has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Gujarat Kidney And Super Speciality's Net Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Gujarat Kidney And Super Speciality ranks #47 out of 668 companies for Net Margin %. This places Gujarat Kidney And Super Speciality in the top 7% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.89. Gujarat Kidney And Super Speciality's value of 16.49% is 471.6% above this benchmark. Historically, Gujarat Kidney And Super Speciality's own Net Margin % has ranged from 7.73 to 23.39 over the past decade. While the company's 10-year median is 14.13 vs. the industry median of 2.89, Gujarat Kidney And Super Speciality has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.89, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gujarat Kidney And Super Speciality's current Net Margin % of 16.49% is 471.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Gujarat Kidney And Super Speciality and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gujarat Kidney And Super Speciality's current Net Margin % is 16.49%, which is 17% above median its own 10-year median of 14.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gujarat Kidney And Super Speciality stock overvalued right now?
Gujarat Kidney And Super Speciality (NSE:GKSL) has a current Net Margin % of 16.49%. The current Net Margin % is 16.49%, which is 17% above median its 10-year median of 14.13 and 471.6% above the Healthcare Providers & Services industry median of 2.89. Gujarat Kidney And Super Speciality's overall GF Score™ is 18/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Gujarat Kidney And Super Speciality (NSE:GKSL), the current Net Margin % is 16.49% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Gujarat Kidney And Super Speciality Business Description
Gujarat Kidney And Super Speciality Ltd is engaged in the business of operating a chain of mid-sized multispeciality hospitals in central Gujarat and providing integrated healthcare services, with a focus on secondary and tertiary care. It offers a range of healthcare services, including General Medicine, General Surgery, Laparoscopic Surgery, Urology, Cardiology, Nephrology, and many more. The company operates in a single segment, namely Medical and Healthcare Services. It generates a substantial portion of revenue from its services to inpatients. Geographically, it operates only in India.
18GF Score
Get the complete analysis for NSE:GKSL
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:GKSL has been successfully added to your 